Teva to Present at the Bank of America Merrill Lynch 2013 Health Care
JERUSALEM -- May 14, 2013
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) will host a live audio
webcast at the Bank of America Merrill Lynch 2013 Health Care Conference in
Las Vegas, NV. Jon Congleton, Senior Vice President and General Manager,
Global CNS will present on Wednesday, May 15, 2013.
What: Teva Presentation at the Bank of America Merrill Lynch 2013 Health
Who: Jon Congleton, Senior Vice President and General Manager, Global CNS,
Teva Pharmaceutical Industries Ltd.
When: Wednesday, May 15, 2013 at 2:20 PM (PT)
Live over the Internet – log on to the Web at the address above and
How: register for the event (approximately 10 minutes before). An archive
of the webcast will be available on Teva’s website.
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) is a leading global
pharmaceutical company, committed to increasing access to high-quality
healthcare by developing, producing and marketing affordable generic drugs as
well as innovative and specialty pharmaceuticals and active pharmaceutical
ingredients. Headquartered in Israel, Teva is the world's leading generic drug
maker, with a global product portfolio of more than 1,000 molecules and a
direct presence in about 60 countries. Teva's branded businesses focus on CNS,
oncology, pain, respiratory and women's health therapeutic areas as well as
biologics. Teva currently employs approximately 46,000 people around the world
and reached $20.3 billion in net revenues in 2012.
Kevin C. Mannix
972 (3) 926-7656
Iris Beck Codner
972 (3) 926-7246
Press spacebar to pause and continue. Press esc to stop.